ZimVie Inc. (NASDAQ:ZIMV) Shares Acquired by Price T Rowe Associates Inc. MD

Price T Rowe Associates Inc. MD grew its position in ZimVie Inc. (NASDAQ:ZIMV) by 8.2% in the 4th quarter, Holdings Channel.com reports. The fund owned 24,571 shares of the company’s stock after acquiring an additional 1,852 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in ZimVie were worth $343,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. Barclays PLC boosted its holdings in shares of ZimVie by 338.4% in the third quarter. Barclays PLC now owns 43,437 shares of the company’s stock valued at $690,000 after acquiring an additional 33,529 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of ZimVie by 66.7% in the third quarter. JPMorgan Chase & Co. now owns 183,419 shares of the company’s stock valued at $2,911,000 after acquiring an additional 73,395 shares during the period. Principal Financial Group Inc. boosted its holdings in shares of ZimVie by 9.8% in the fourth quarter. Principal Financial Group Inc. now owns 19,054 shares of the company’s stock valued at $266,000 after acquiring an additional 1,702 shares during the period. Bank of New York Mellon Corp raised its stake in shares of ZimVie by 0.9% during the fourth quarter. Bank of New York Mellon Corp now owns 100,638 shares of the company’s stock worth $1,404,000 after purchasing an additional 943 shares during the last quarter. Finally, LPL Financial LLC purchased a new stake in shares of ZimVie during the fourth quarter worth approximately $993,000. 95.63% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the company. B. Riley assumed coverage on ZimVie in a research note on Thursday, April 10th. They set a “buy” rating and a $16.00 price target for the company. Needham & Company LLC restated a “hold” rating on shares of ZimVie in a research note on Wednesday, April 9th.

ZimVie Price Performance

ZimVie stock opened at $8.72 on Thursday. ZimVie Inc. has a 12 month low of $8.56 and a 12 month high of $22.40. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.94 and a quick ratio of 1.38. The business has a 50 day simple moving average of $10.08 and a 200-day simple moving average of $12.55. The stock has a market capitalization of $242.83 million, a PE ratio of -0.67 and a beta of 2.16.

ZimVie (NASDAQ:ZIMV) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.06. The firm had revenue of $112.00 million during the quarter, compared to analysts’ expectations of $113.10 million. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. Equities analysts predict that ZimVie Inc. will post 0.6 earnings per share for the current year.

ZimVie Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.